Berkeley Lights, Inc.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PhenomeX is enabling researchers to take advantage of each cell's full potential and launch the next phase of functional cell biology that will improve human health. We give researchers the most thorough understanding of how cells function and a detailed picture of each cell's behaviour.

PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. , March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health.

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

Berkeley Lights, Inc. (NASDAQ:BLI ) Q4 2022 Results Conference Call February 23, 2023 4:30 PM ET Company Participants Suzanne Hatcher - VP, Communications and IR Dr. Siddhartha Kadia - CEO Mehul Joshi - CFO Conference Call Participants Chad Wiatrowski - Cowen Vidyun Bais - BTIG Matt Larew - William Blair Gaurav Goparaju - Berenberg Operator Ladies and gentlemen, good afternoon. My name is Abbie, and I will be your conference operator today.

Berkeley Lights, Inc. (BLI) Q4 2022 Earnings Call Transcript

EMERYVILLE, Calif. , Feb. 23, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.

Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results

IsoPlexis Corp

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IsoPlexis Corporation (NasdaqGS: ISO) to Berkeley Lights, Inc. (NasdaqGS: BLI). Under the terms of the proposed transaction, shareholders of IsoPlexis will receive 0.612 shares of Berkeley Lights for each share of IsoPlexis that they own.

ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO

EMERYVILLE, Calif. , Feb. 13, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.

Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2023) - Kaskela Law LLC announces that it is investigating Berkeley Lights, Inc. (NASDAQ: BLI) on behalf of the company's long-term investors.Recently a securities fraud complaint was filed against Berkeley Lights on behalf of certain investors who purchased shares of the company's stock between July 17, 2020 and January 5, 2022.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Berkeley Lights, Inc. (BLI) and Encourages Long-Term BLI Investors to Contact the Firm

NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation ("IsoPlexis" or the "Company") (NASDAQ: ISO) in connection with its proposed acquisition by Berkeley Lights, Inc. ("Berkeley Lights") (NASDAQ: BLI). Under the merger agreement, the Company's shareholders will receive 0.612 shares of Berkeley Lights common stock for each IsoPlexis share, representing implied per-share consideration of $1.44 based upon Berkeley Lights' February 2, 2023 closing price of $2.36.

SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation

EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended December 31, 2022.

Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development (CLD).

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

Berkeley Lights, Inc. went public in July 2020, raising around $178 million in an IPO. The firm recently announced a merger with IsoPlexis Corporation, with the combined entity to be renamed PhenomeX.

Berkeley Lights Generates Further Losses Amid Merger Plan

EMERYVILLE, Calif. , Jan. 3, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the Company will be participating in the upcoming 41st Annual J.P.

Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference

NEW YORK--( BUSINESS WIRE )--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Berkeley Lights, Inc. (NASDAQ: BLI) and Isoplexis Corporation is fair to Berkeley shareholders. Under the terms of the agreement, IsoPlexis shareholders will receive 0.612 shares of Berkeley stock for each IsoPlexis share they hold. Following the close of the transaction, Berkeley shareholders will own approximately 75.2% of the combined company.

BLI STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Berkeley Lights, Inc. Is Fair to Shareholders

EMERYVILLE, Calif. , Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Therapeutics (AE&T) meeting, being held from December 4 - 8, 2022, in San Diego, California.

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutics Conference

Enables access to a broad range of biodiversity to find unique antibodies against challenging targets EMERYVILLE, Calif. , Nov. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ: BLI), a leader in digital cell biology, today announced the launch of the Opto® Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon® platform.

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

Aeglea BioTherapeutics

Invitae

OmniAb Inc

Hot penny stocks to watch after October's CPI report. The post Best Penny Stocks To Buy Now That CPI Is Out?

Best Penny Stocks To Buy Now That CPI Is Out? 4 To Watch Before Next Week

EMERYVILLE, Calif. and MELBOURNE, Australia , Nov. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's leading universities, has implemented the use of the Berkeley Lights Beacon® system and Opto® Plasma B Discovery workflow for antibody discovery research.

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

Berkeley Lights, Inc. (NASDAQ:BLI ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Suzanne Hatcher – Vice President-Communications and Investor Relations Siddhartha Kadia – Chief Executive Officer Mehul Joshi – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Chad Wiatrowski – Cowen Operator Good afternoon. My name is Chris and I will be your conference operator today.

Berkeley Lights, Inc. (BLI) Q3 2022 Earnings Call Transcript

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -18.52% and 1.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Berkeley Lights, Inc. (BLI) Reports Q3 Loss, Misses Revenue Estimates

EMERYVILLE, Calif. , Nov. 8, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended September 30, 2022.

Berkeley Lights Reports Third Quarter 2022 Financial Results

EMERYVILLE, Calif. , Nov. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced it will host its 2022 Investor Day on Friday, November 18 starting at 9:00 a.m.

Berkeley Lights to Host Upcoming Investor Day

EMERYVILLE, Calif. , Oct. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the third quarter 2022 after market on Tuesday, November 8, 2022.

Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022

Company to present on its Bispecifics Heterodimer Assay and Custom Productivity Assay for the Opto ®  Cell Line Development workflow GSK Vaccines, Rockville to present on their successful implementation of the Berkeley Lights' Beacon ®  technology for accelerated cell line development for complex subunit vaccine candidates EMERYVILLE, Calif. , Sept. 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the Bioprocess International 2022 Conference (BPI) being held from September 27 - 30, 2022, at the Boston Convention and Exhibition Center.

Berkeley Lights to Participate in the BioProcess International 2022 Conference

EMERYVILLE, Calif. , Sept. 19, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal officer and corporate secretary, effective immediately.

Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer

Berkeley Lights, Inc. (NASDAQ:BLI ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Suzanne Hatcher - Vice President, Communications & Investor Relations Siddhartha Kadia - Chief Executive Officer Mehul Joshi - Chief Financial Officer Lucas S. Vitale - Chief Human Resources Officer Conference Call Participants Tejas Savant - Morgan Stanley Daniel Arias - Stifel Brian Weinstein - William Blair Julia Chen - JP Morgan Steven Mah - Cowen Mark Massaro - BTIG Gaurav Goparaju - Berenberg Capital Markets Operator Thank you for standing by.

Berkeley Lights, Inc. (BLI) CEO Siddhartha Kadia on Q2 2022 Results - Earnings Call Transcript

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -26.67% and 14.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Berkeley Lights, Inc. Stock (BLI)